Humanigen is based in Burlingame, California. It has raised $72M in total funding. Latest round: Series C.
Humanigen funding overview
Humanigen is based in Burlingame, California. Humanigen has raised $72M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in June 2020. The round record for Humanigen runs through 2020; nothing later has been disclosed. Investors on record include Venrock Healthcare Capital Partners, Surveyor Capital, HealthCor, Valiant Capital Partners, First Light Asset Management, Ghost Tree Capital. 6 distinct backers are named across the disclosed rounds.
Humanigen at a glance
Total raised
$72M
Latest round
Series C
Latest round date
June 2020
Headquarters
Burlingame, California
Notable investors
Venrock Healthcare Capital Partners, Surveyor Capital, HealthCor, Valiant Capital Partners, First Light Asset Management, Ghost Tree Capital
Frequently asked about Humanigen funding
How much has Humanigen raised?
Humanigen has raised $72M in total disclosed funding across the rounds on record.
Who has invested in Humanigen?
Venrock Healthcare Capital Partners, Surveyor Capital, HealthCor, Valiant Capital Partners, First Light Asset Management, Ghost Tree Capital are named among the investors backing Humanigen.
What was the latest Humanigen funding round?
The most recent disclosed round is a Series C, announced in June 2020.
Where is Humanigen based?
Humanigen is based in Burlingame, California.
When did Humanigen last raise?
The last disclosed Humanigen round closed in June 2020 at Series C.
Humanigen totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Burlingame below to benchmark round size and investor mix.
